Biboulet P, Capdevila X, Aubas P, Rubenovitch J, Deschodt J, d'Athis F
Department of Anesthesiology and Critical Care, Lapeyronie University Hospital, Montpellier, France.
Anesthesiology. 1998 Jun;88(6):1487-94. doi: 10.1097/00000542-199806000-00011.
Many cases of cauda equina syndrome after maldistribution of local anesthetics during continuous spinal anesthesia have been reported. In experiments, a caudad route of catheter travel and the use of hyperbaric agents have been shown to induce these limited blocks. The aim of this clinical study was to verify this hypothesis and seek a predictive factor for the maldistribution of bupivacaine.
Continuous spinal anesthesia via a 19-gauge end port spinal catheter was performed in 80 elderly patients randomly assigned to receive either isobaric or hyperbaric solutions. Successive injections of 2.5 mg bupivacaine were performed at 5-min intervals until a sensory level at or cranial to T8 was obtained. Maldistribution was defined by a sensory level caudal to T12 despite a total dose of 17.5 mg of either isobaric or hyperbaric bupivacaine. After surgery, all catheters were injected with contrast media and examined radiographically.
The frequency of maldistribution was not significantly different in the isobaric and hyperbaric groups. A caudally oriented catheter tip was found to be a major cause of maldistribution (P < 10(-5)). A thoracic sensory level could be reached in all patients presenting a limited block by simply changing the baricity of the bupivacaine, the position of the patient, or both. The sensory level obtained 10 min after the first injection of 2.5 mg isobaric or hyperbaric bupivacaine was found to be a predictive factor of maldistribution.
Hyperbaric solutions do not appear to be a clinical factor in the development of limited block. The principle factor causing the maldistribution of bupivacaine is the caudal orientation of the tip of the end-hole catheter rather than its level or the route of catheter travel.
已有多例关于连续脊麻期间局部麻醉药分布不均导致马尾综合征的报道。实验表明,导管向尾端走行以及使用高压剂会引发这些局限性阻滞。本临床研究的目的是验证这一假说,并寻找布比卡因分布不均的预测因素。
对80例老年患者实施经19号端孔脊麻导管的连续脊麻,这些患者被随机分配接受等比重或重比重溶液。每隔5分钟依次注射2.5mg布比卡因,直至获得T8或T8以上的感觉平面。尽管等比重或重比重布比卡因的总剂量达到17.5mg,但感觉平面在T12以下则定义为分布不均。术后,所有导管均注入造影剂并进行X线检查。
等比重组和重比重组分布不均的发生率无显著差异。发现导管尖端向尾端是分布不均的主要原因(P<10⁻⁵)。对于所有出现局限性阻滞的患者,只需改变布比卡因的比重、患者体位或两者同时改变,即可达到胸段感觉平面。首次注射2.5mg等比重或重比重布比卡因10分钟后获得的感觉平面被发现是分布不均的预测因素。
重比重溶液似乎不是导致局限性阻滞的临床因素。导致布比卡因分布不均的主要因素是端孔导管尖端的向尾端方向,而非其位置或导管走行路径。